Search Results 211-220 of 11741 for Drug-resistant TB

  1. Medical Research & Education - Mayo Clinic News Network

    New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant · Hidden mutation leads to groundbreaking genetic ...

  2. Medical Research & Education - Mayo Clinic News Network

    Latest stories · New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant · Hidden mutation leads to ...

  3. Antimicrobial agents - Infectious Diseases Lab - Mayo Clinic Research

    Mayo Clinic's Infectious Diseases Laboratory, led by Robin Patel, M.D., investigates antimicrobial agents to combat multidrug-resistant bacteria.

  4. Medical Research & Education - Mayo Clinic News Network

    ... drug-resistant epilepsy. For Anthony Maita, 'Buddy' is not just any other dog ... Mayo Clinic Minute: How precise diagnosis of lymphoma offers patients best ...

  5. Medical Research & Education - Mayo Clinic News Network

    ... drug-resistant. Featured News. New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant epilepsy. Alison ...

  6. Pulmonary Medicine Physicians - Medical Professionals - Mayo Clinic

    ... Tuberculosis, Tick-borne disease, COVID-19-associated MIS-C, Endocarditis, Osteomyelitis, Cellulitis, Fever of ... Multidrug-resistant organism infection · Sadia ...

  7. A Study Of The Effectiveness And Safety Of Infliximab For Pediatric Patients With Inflammatory Bowel Disease - Mayo Clinic

    Is considered eligible according to the tuberculosis (TB) Screening criteria specified in protocol; Must have negative stool results for enteric pathogens ...

  8. Medical Research & Education - Mayo Clinic News Network

    New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant epilepsy. Alison Satake. April 7, 2025.

  9. Effectiveness and Safety of Pembrolizumab for Participants with Resectable Stage IIB or IIIA Non-small Cell Lung Cancer - Mayo Clinic

    About this study. This trial will evaluate the safety and effectiveness of pembrolizumab (MK-3475) in combination with platinum doublet neoadjuvant ...

  10. Medical Research & Education - Mayo Clinic News Network

    New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant epilepsy. Alison Satake. April 7, 2025.